Price Alert

Comera Life Sciences Inc... (CMRAW)

NASDAQ: CMRAW · Real-Time Price · USD

0.02

null (null%)

At close: Sep 17, 2024, 10:00 PM

Comera Life Sciences Statistics

Share Statistics

Comera Life Sciences has 318.55K shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding	318.55K
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Institutions (%)	n/a
Shares Floating	n/a
Failed to Deliver (FTD) Shares	n/a
FTD / Avg. Volume	n/a

Short Selling Information

Short Interest	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Valuation Ratios

The PE ratio is -0.71 and the forward PE ratio is null. Comera Life Sciences's PEG ratio is 0.

PE Ratio	-0.71
Forward PE	n/a
PS Ratio	20.31
Forward PS	n/a
PB Ratio	-2.06
P/FCF Ratio	-1.31
PEG Ratio	0

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Comera Life Sciences.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.61, with a Debt / Equity ratio of -0.12.

Current Ratio	0.61
Quick Ratio	0.61
Debt / Equity	-0.12
Debt / EBITDA	-0.04
Debt / FCF	-0.08
Interest Coverage	-587.02

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$52.76K
Profits Per Employee	$-1.5M
Employee Count	12
Asset Turnover	0.17
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is -20.43, so Comera Life Sciences's price volatility has been lower than the market average.

Beta	-20.43
52-Week Price Change	n/a
50-Day Moving Average	0.01
200-Day Moving Average	0.03
Relative Strength Index (RSI)	43.66
Average Volume (20 Days)	n/a

Income Statement

In the last 12 months, Comera Life Sciences had revenue of 633.1K and earned -18M in profits. Earnings per share was -1.76.

Revenue	633.1K
Gross Profit	422.71K
Operating Income	-11.97M
Net Income	-18M
EBITDA	-17.89M
EBIT	-17.98M
Earnings Per Share (EPS)	-1.76

Full Income Statement

Balance Sheet

The company has 446.61K in cash and 775.05K in debt, giving a net cash position of -328.44K.

Cash & Cash Equivalents	446.61K
Total Debt	775.05K
Net Cash	-328.44K
Retained Earnings	-34.9M
Total Assets	3.07M
Working Capital	-301.92K

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.77M and capital expenditures -28.61K, giving a free cash flow of -9.8M.

Operating Cash Flow	-9.77M
Capital Expenditures	-28.61K
Free Cash Flow	-9.8M
FCF Per Share	-0.94

Full Cash Flow Statement

Margins

Gross margin is 66.77%, with operating and profit margins of -1890.69% and -2843.79%.

Gross Margin	66.77%
Operating Margin	-1890.69%
Pretax Margin	-2843.79%
Profit Margin	-2843.79%
EBITDA Margin	-2825.23%
EBIT Margin	-1890.69%
FCF Margin	-1547.99%

Dividends & Yields

CMRAW does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for CMRAW.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-28.11
Piotroski F-Score	2